07:15:04 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Beskrivning

LandDanmark
ListaSpotlight DK
SektorHälsovård
IndustriLäkemedel & Handel
CS Medica är ett danskt bolag verksamma inom medicinteknik. Bolaget är specialiserade inom utveckling av medicintekniska produkter. Portföljen inkluderar produkter som innehåller medicinsk cannabis (CBD), med störst inriktning mot kosttillskott och diverse behandlingsvård. Produkterna används exempelvis av patienter som lider av psoriasis, artros och håravfall. Störst verksamhet återfinns inom den nordiska marknaden, där produkterna vidaresäljs under eget varumärke.

Kalender

2021-12-09 Årsstämma 2022
2021-11-18 Bokslutskommuniké 2021
2021-09-14 08:00:00

Today is the first day of trading in CS MEDICA A/S's ("CS MEDICA" or the "Company")  shares and warrants. CS MEDICA's shares are traded under the ticker "CSMED" with ISIN DK0061668225 and the Company's warrants are traded under the ticker "CSMED TO 1" with ISIN DK0061668308.

Prior to listing at Spotlight Stock Market, CS MEDICA conducted a successful IPO which was subscribed to a total of approx. 158 percent. The capitalization provided the Company with initially approx. DKK 22.3 million (before issue costs, offset of bridge loan financing and compensation).

The number of shares in the Company amounts to 10,902,000 and the share capital is DKK 708,630 after the IPO. In addition, there are a total of 1,160,800 outstanding warrants of series TO 1. The exercise period of the warrants is planned to take place between August 18[th] - September 1[st], 2022. Each warrant entitles the holder to subscribe for one new share in the Company at a price of DKK 9.30 per share. Upon full exercise of all attached warrants, the Company will receive approx. DKK 10.8 million before issue costs.

Advisors
CS MEDICA has in connection with the issue of units appointed Sedermera Fondkommission as financial advisor, Markets & Corporate Law Nordic AB as the legal advisor, Nordic Issuing as issuing agent, and Nordnet Bank AB as selling agent.